Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multivariate outcome research in arthritis. Implications for sample sizes.

J E Hewett, S K Anderson, C S Johnson

    Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association
    |December 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Final report on North Central Cancer Treatment Group N0877 (alliance): A phase II randomized, placebo-controlled trial of chemoradiotherapy with or without dasatinib for glioblastoma.

    Neuro-oncology·2025
    Same author

    Genetic risk in endolysosomal network genes correlates with endolysosomal dysfunction across neural cell types in Alzheimer's disease.

    bioRxiv : the preprint server for biology·2025
    Same author

    Effects of external influences on synthetic cannabinoid trends in New Zealand, 2014 to 2020.

    Forensic science international·2020
    Same author

    Festival testing: A survey of suspected drugs seized from New Zealand music festivals, December 2018 to March 2019.

    Forensic science international·2020
    Same author

    The phenomenon of para-Fluorophenylpiperazine (pFPP) in combination with the synthetic cannabinoid AMB-FUBINACA in seized plant material in New Zealand.

    Forensic science international·2020
    Same author

    Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).

    Journal of neuro-oncology·2019

    Choosing the right statistical analysis is key for efficient sample size in research. This study compares methods for multivariate outcomes, aiding researchers in selecting the most sample-size-efficient approach.

    Area of Science:

    • Biostatistics
    • Clinical Trials
    • Research Methodology

    Background:

    • Appropriate sample size planning is crucial for research success.
    • Practical limitations in subject availability often challenge sample size determination.
    • Limited literature addresses the impact of statistical methods on required sample size.

    Purpose of the Study:

    • To explore the sample size implications of different statistical methods for comparing two populations with multivariate outcomes.
    • To guide researchers in selecting analysis techniques that optimize sample size efficiency.
    • To provide practical insights using a real-world pain management study.

    Main Methods:

    • Comparison of three common statistical methods for multivariate outcome analysis.

    Related Experiment Videos

  • Evaluation of sample size requirements for each method.
  • Illustration of concepts using data from a rheumatoid arthritis pain management study.

    • Main Results:

    • Different statistical methods have varying sample size implications for multivariate data.
    • The choice of analysis significantly impacts the number of subjects needed.
    • The study provides a framework for assessing method-specific sample size needs.

    Conclusions:

    • Selecting the most sample-size-efficient statistical method is vital when subject numbers are limited.
    • Researchers should consider sample size implications early in the study design process.
    • This work aids in optimizing resource allocation for clinical trials with multivariate outcomes.